BRIEF RESEARCH REPORT
Published on 26 Jun 2025
Efficacy and safety of ruxolitinib in adult patients with refractory rheumatic disease-associated macrophage activation syndrome
doi 10.3389/fimmu.2025.1604648
- 479 views
77
Total downloads
1,420
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.